dihexa half-life 12 days AngIV-Analog Dihexa Rescues Cognitive Impairment

While not currently on the WADA list of banned substances (Wada-ama.org 2018), due to what some individuals would term as the synthetic nature of BPC 157, there may be issues associated with the use of this peptide, as seen by some sport organisations

Tirzepatide is an investigational dual incretin receptor agonist designed to activate two key receptor systems involved in metabolic regulation: GLP-1 receptor GIP receptor This receptor profile places Tirzepatide between Semaglutide and Retatrutide in mechanistic breadth

The Khavinson and Ashmarin groups systematised it on Russian bioactive peptides

doi:10.1097/CRD.0000000000000513 Kruse T, Hansen JL, Dahl K, et al